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A full-length cDNA for a rat type II activin receplor was cloned by hybridization from a rat ovary cDNA library. The deduced amino acid sequence 
(513 residues) containing a single membrane-spanning domain and an intracellular kinasc domain with predicted scrinc/thrconinc spccilicity. The 
amino acid sequence is99.8% and 99.4% identical in the coding region with the previously cloned mouse and human type II activin receptor, and 
only 66.7% identical in the coding region with the previously Dodd rut type Ill3 activin receptor. We examined the c&et of PMSG-hCG on the 
mRNA level of type 11 activin receptor in immature rat ovaries. Northern blot analysis of ovarian RNA revealed two mRNAs (3.0 kb and G.0 
kb). 
Ovary; Activin receptor; mRNA 
1, INTRODUCTION 
Activins, dimers of the /? subunits of inhibin Gs, or 
BE), which stimulate FSH secretion in the anterior pitu- 
itary gland have been isolated from the mammalian 
follicular fluids [ 1,2]. They belong to a member of TGF- 
p superfamily which includes TGF-/Is, MUllerian inhib- 
iting substance, bone morphogenetic proteins, the prod- 
uct of decapentaplegic gene complex of Drosophih and 
Vgl gene product of Xer~oyus [3]. Acdvins have an ex- 
tensive anatomical distribution and are implicated in 
the regulation of many biological processes, including 
the proliferation of many cell lines [4-S], control of the 
secretion and expression of the anterior pituitary 
hormones FSH, GH, and ACTH [ 1 I9 neuronal survival 
[7,8], hypothalamic oxytocin secretion [9], erythropoi- 
esis [lO,ll], and early embryonic development [12-141. 
In the ovary, the LH-stimulated androstenedione pro- 
ductioll was suppressed, and FSH-enhanced aromatase 
activity was stimulated by activin [l S,lG]. A previous 
study reported that administration of PMSG led to a 
increase in the expression of all three inhibin subunits 
(a, PA, and Bn) whereas injection of hCG cause a de- 
creased in the level of the respective mRNA in vivo 
system [17]. Therefore, activin has been suggested to 
play important local roles in the modulation of gonadal 
function. However, an understanding of the molecular 
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mechanism of activin action has to be determined. Re- 
cently, activin receptors were cloned in several species, 
and subtypes were reported [l&22]. 
We report here the cloning of rat type II activin recep- 
tor and the effect of PMSG-hCG on the mRNA levels 
of this receptor in immature rat ovaries. 
2. MATERIALS AND METHODS 
2. I. isohriorr arrd sryurnce detrrrni~rariurr of af acrivirr recepror 
A slzc-selcctcti (1.5-5 kb) randomly primed rat ovarinn cDNA was 
prepared by revcrsc transcription of poly(A)’ RNA. The end of the 
cDNA were blunted with T4 DNA polymcrasc and EcoRI adaptors 
were added. The cDNA was ligated to the yector &tlO and packed 
with Stratagcnc Gigapack Gold. The library contains I .5 x IO” inde- 
pendent recombinants. and was amplilicd. This library (5 x IO5 clones) 
was scrccncd with nick translated “P-labeled I .4-kilobasc (kb) Accl 
frdgmCn1 (780-2194) from the mouse type II activin receptor clone 
[18]. Nylon membrdnes were hybridized and washed succcssivcly in
I x SSPE (0.18 M NaCI, 0.01 M sodium phosphate. 1 mM EDTA. pH 
7.7). 0.1% SDS for I5 min at 42°C and 0.1 x SSPE, 0.1% SDS for IO 
min at 65°C. Srvcral clonea wcrc idendficd, and one clone was sclcctcd 
for squencc analysis. Thcsc clones were subcloned into M I3mp and 
single-stranded DNA templates wcrc prepared for sequcncc dctcrmi- 
nation. Sequencing ofstrands of DNA was done by the didcoxy chain 
termination method [23]. 
2.2. Exrracriott o/RNA md North-~; blor analysis 
Twenty&c-day-old immature female mts of Wistar stain wet-c 
primed with 3OIU PMSG alone or 3OIU PMSG plus 2OIU hCG 60 
h later. After each rat was sacrificed at sclccted intervals, ovaries were 
rcmovcd and immediately stored in liquid nitrogen until extracting 
RNA for Northern blot analysis. Rat type 11 activin rcceplor mRNA 
probe was prepared using mRNA probe synthesis kit. Total RNA (15 
~6) cxtractcd from the ovaries by the acid guanidinium ihitiyartitd 
phenoVchloroform extraction method was fractionated by elcctropho- 
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rcsis through a 1% agarose/formaldehyde gels [24]. The RNAs were 
transferred to a nylon membrane (Biodyae, !CN) [25]. Blots were 
3. RESULTS AND DISCUSSION 
prehybridized for 6 h at 68’C and then hybridized overnight at GS°C 
with a digoxigenin-labeled RNA probe. Under the standard protocol 
Fig. 1 shows the 2277-nucleotides sequence of the 
of nucleic acid detection kit (Boehringer-Mannheim), autoradiogra- 
cloned cDNA and amino acid sequence deduced for the 
phic bands were quantitated by dcnsitometric s anning to be stander- rat type II activin receptor. The Arst methionine in the 
lized against he corresponding amount of /?-actin mRNA. sequence was considered the initiator codon. This was 
2.3. SyrrrAesis of RNA probe 
followed by a amino acid sequence having the charac- 
Rat activin receptor cDNA was subcloned into Bluescript and lin- 
teristics of a signal peptide with a cleavage site as de- 
earized by BwHI. Digoxigcnin-labeled activin receptor RNA probe 
fined by von Meijne [26]. As in mouse type II activin 
corresponding to -21 to 225G was produced by in vitro transcription receptor, the 19 amino acid stretch at the amino-termi- 
with T3 RNA polymerase and RNA labeling kit (Boehringer- nus is assumed to be a single peptide and a single puta- 
Mannheim). Digoxigenin-labeledp-actin RNA probe was obtained by 
the same method. 
tive 26 residue membrane-spanning region occurs be- 
tween amino acids 136 and 161 [18]. Therefore, the 
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CAGCATCCATCTCTTGAAOATATGCAGCAAG~TTGTGCATAAAAAAAAGAGGCCCGTRTAAGAGATTATTGGCAGAAACACGCAGGA 1350 
GlnlllsPmSerkuGluA~p~etGlnGIuValValValHiaLyaLysLysArgProVlrlLcvhrgAspTyrTrpGl~~Ly~HlsAlaGly 450 
ATCGCAATGCTCTGTGAAACGATAGAAGAATGQOGGATCA~GA~CAGAAGCCAGG~ATCAG~TGGATGTGTAOGTGAAAOAATTACT 1440 
MctAlaMetkuCysGluThrllcOluGluCysTrpArplllsA~pAlaGluAIPA:glcuSerAlnGl~Cy6ValGlyGluArgIleTl~r 480 
CAGATGCA~GA‘~AACAAATATAATTACTACACAGOACCTCACAATGGTGACAAATGTTGA~~~~T~~~AAAGAA 1530 
GlnMetGlnArgLouThrAsnllollQThrThrGluAaplloVslThrVolVnlThrMctV~lThrAsnValAspl’hcPmProLy~Glu 610 
TCTAGTCTATGATGGTTGCACCATCTGTCCACACTGAGAATCGGGACTCTGAACTGGAGL~GbAAGCTAAGGAAA~GbTAG’PTTATT 1620 
S9rS0r!& 513 
TT~GTOTGAAATGAGTAGGO~GCCTCCGGI;ACACGTATGCAAGCAGCCCC~GTGGAAAGCATGGATTGGGAGACTTCCTGCAGLGTCT 1710 
GCAACAffiGATATGhAGGGGGTCTAAGGGGAAACTGCGAACTGTAAAGAACMCTQAAAACTTACACQA4GAAT~~~CCT~C~MAT l6QQ 
CAAUGAT~~TOGACCTGGCTAATCAAGTAT~GAAAACTGACATCAGATTT~~AATGT~GTCAGAAOACABAATTCCTTAAATQA 1890 
ACTACTGCTATTTTTTTTAAATCAAAAACTT~’OAT~CAGATTTTAAAAACCGTAA~TTTTATTGCATTGCTG~OTTTCTATMAT 1980 
OA~ATTGTAATGCCAACATGACACAG~TQTGAATGTGTACTOTG~GCTG~~O~TACATAGTCATCAAAOT~~A~A~A~G 2070 
AOGCTTCCAAGCATTACTTTAACCTCCCTCAACAAGGPATACCTCAOTTCCACGQPTGCTAAATTATAAAATTGAAAACACT~~AOAAT 21f3Q 
1’?GAATP.9A~AD?CCA~TTRaTbACAAPGTA~ACAbACTCICTGTOTSAT~AAGAAAAAAfGGTAAGCTATG~TA~~~AATA 2260 
GAAGCT 2256 
Fig* I. Nucleotide and ddud amino acid sequence of rat type II uctivin receptor. The single peptide and transmcmbrane domain are indicated 
bY a single underline. The kinase domain sindicated by arrows. Potential sites of N-glycasylation arc indicated by double underlines. 
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Fig. 2. Detailed comparison of the amino acid sequence of the rat, 
mouse and human type II receptors: identical residues are rcprescntcd 
by a dot. The numbering of the arnino acids is indicated on the right. 
mature rat type II activin receptor is predicted to be a 
494 amino acid membrane protein of M, 56,000 with a 
11 G amino acid N-terminal extracellular ligand binding 
domain, and a 352 amino acid intracellular signailing 
domain with predicted serine/threonine specificity. The 
position of all cysteines, as well as sites of N-linked 
glycosylation are conserved, There are two potential 
sites of N-linked glycosylation in the N-terminal ex- 
tracellular domain. 
The amino acid sequence is 99.8% and 99.4% identi- 
cal in the coding region with the previously cloned 
mouse and lzuman type II activin receptors (Fig. 2), and 
is only 66.7% identical in the coding region with the 
previously cloned rat type IIB activin receptor (Fig. 3). 
The existence of heterogeneity in the activin receptor 
population has been suggested by the widespread ac- 
tions of activin. In addition, two types of activin recep- 
tor were detected on Friend leukemia and embryonal 
carcinoma cells [27]. According to our data, this degree 
of sequence divergence indicate the difference between 
the rat type II and the rat type III3 receptor. However, 
the serine/threonine kinase show a high degree of ho- 
mology within the two receptors than the ligand binding 
or transmembrane domain. The availability of a cDNA 
for type II activin receptor might allow us to study 
structure-function analysis of this receptor. Moreover, 
the existence of distinct activin receptors may contribute 
significantly to the varied biological effects of activin. 
In granulosa cell culture, addition of FSH induced a 
7-8-fold rise in the number of activin binding sites with- 
out alternation of the binding affinity [28]. Moreover, 
it has been reported that activin increased FSH receptor 
content [29] and augmented the FSH stimulation of 
progesterone production and LH receptor induction. 
Therefore, the specific activin receptors in the granulosa 
cells may mediate the observed effects of activin on 
granulosa ceil differentiation. On the other hand, ac- 
tivin-binding protein was purified from rat ovary [30] 
and bovine pituitary [3 l] and was identical to follistatin. 
It was reported that FSH induced the production of 
follistatin in granulosa cell culture [32]!. In order to in- 
vestigate the regulation of activin activity, it might be 
essential to know the dynamic relationship hctwcen pro- 
duction of follistatin and activin receptor in the ovary. 
Therefore it is possible that activin may exert local ef- 
fects such as the modulation of the production of gona- 
dotropin receptor through their own receptor which 
might be affected by the existence of follistatin. As 
shown in Fig. 4, Northetn blot analysis of ovarian RNA 
revealed a major mRNA of 6.0 kb nucleotides and a 
minor that of 3.0 kb nucleotides. Although the intensity 
of 6.0 kb band did not change significantly after PMSG 
administration, hCG administration caused an increase 
in activin receptor messenger level and S-fold increase 
of control level by day 3. Thus, the mRNA levels of 
activin receptor in immature rat ovary has been induced 
according to the maturation of follicles and even after 
ovulation it continued to increase. The physiological 
roles of accumulation of activin receptor levels after 
PMSG-hCG priming in the female rat are not known, 
and we believe that our results are of significance in 
ascertaining the existence of a specific receptor in rat 
ovary, and contribute further insight into the mecha- 
nism of regulation of ovarian functicn. 
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Fig. 5. &tailed comparison ofthc a -_;-* ..iA C*n..D”CP oftbp “,t type ..,..I” LCAY .Jw?..+.‘_ 
II and the rat type III3 activin receptors: identical residues aFe repre- 
srnted by a dot. The numbwing of the xmino acids is indicatd on the 
right. 
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Fig. 4. The effect of PMSG and hCG treatment on rat type II activin receptor mR?dA levels in immature rat ovary. From each point I5 pg of 
total RNA was prepared and fractionated through a 1% agarosc gel and blotted as described in Materials aed Methods. Blots were probed with 
digoxigenin-labeled rat type II activin receptor RNA. (A) The filters wcrc exposed to Kodak XRP Rim. (B) Autoradiographs were quantitated 
by densitometric s anning, and the increase in activin receptor mRNA (6.0 kb band) relative toB-actin is expressed as arbitrary units. The mRNA 
level at each time point is expressed as the fold increase over day -2. The results hown arc representative of threl: experiments. 
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